| Facilitated percutaneous coronary intervention for acute myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 11050381 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Facilitated percutaneous coronary intervention is a treatment strategy for acute myocardial infarction in which patients are given medications in the emergency department that open or partially open infarct-related coronary arteries. The patients are then taken to the cardiac catheterization laboratory for early angiography and angioplasty or placement of a coronary artery stent. Preliminary evidence suggests that this treatment strategy may offer outcomes similar to or better than primary angioplasty and superior to solitary fibrinolytic therapy. In addition, the treatment can be started even in hospitals that do not have primary intervention capability. Currently, large-scale clinical trials are assessing the impact of the facilitated percutaneous coronary intervention treatment strategy on the clinical outcomes of patients with acute myocardial infarction. |
| | |
Authors:
|
M R Sayre |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The Journal of emergency medicine Volume: 19 ISSN: 0736-4679 ISO Abbreviation: J Emerg Med Publication Date: 2000 Oct |
Date Detail:
|
Created Date: 2000-11-29 Completed Date: 2000-11-29 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8412174 Medline TA: J Emerg Med Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 27S-32S Citation Subset: IM |
Affiliation:
|
Department of Emergency Medicine, University of Cincinnati, Cincinnati, Ohio 45267-0769, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary* Clinical Trials as Topic Combined Modality Therapy Coronary Angiography Emergency Service, Hospital Female Fibrinolytic Agents / administration & dosage* Heart Catheterization Humans Male Myocardial Infarction / diagnosis, mortality, therapy* Platelet Aggregation Inhibitors / administration & dosage* Prognosis Survival Rate Thrombolytic Therapy / methods* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents; 0/Platelet Aggregation Inhibitors |
| Comments/Corrections | |
Erratum In:
|
J Emerg Med 2001 Jan;20(1):105 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Glycoprotein IIb/IIIa receptor inhibitor use in unstable angina/non-ST-segment elevation myocardial ...
Next Document: Brain-derived neurotrophic factor is an anterograde survival factor in the rat visual system.